Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Management of human epidermal growth factor receptor inhibitors-related acneiform rash: A position paper based on the first Europe/USA Delphi consensus process.
Apalla Z, Freites-Martinez A, Grafanaki K, Ortiz-Brugues A, Nikolaou V, Fattore D, Sollena P, Deverapalli S, Babakoohi S, Galimont A, Kluger N, Beylot-Barry M, Larocca C, Iriarte C, Smith J, Tattersall I, Dodiuk-Gad R, Sauder M, Carrera C, Kwong B, Whitley M, Leboeuf N, Romano P, Starace M, Mateeva V, Riganti J, Hirner J, Patel AB, Reyes-Habito CM, Kraehenbuehl L, Kheterpal M, Fida M, Hassel J, Lacouture M, Sibaud V. Apalla Z, et al. Among authors: reyes habito cm. J Eur Acad Dermatol Venereol. 2024 Oct 26. doi: 10.1111/jdv.20391. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 39460590
Multinational Association of Supportive Care in Cancer (MASCC) clinical practice guidelines for the prevention and management of acute radiation dermatitis: international Delphi consensus-based recommendations.
Behroozian T, Bonomo P, Patel P, Kanee L, Finkelstein S, van den Hurk C, Chow E, Wolf JR; Multinational Association of Supportive Care in Cancer (MASCC) Oncodermatology Study Group Radiation Dermatitis Guidelines Working Group. Behroozian T, et al. Lancet Oncol. 2023 Apr;24(4):e172-e185. doi: 10.1016/S1470-2045(23)00067-0. Lancet Oncol. 2023. PMID: 36990615 Review.